| Guo, Wei |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
ALTN-III-04, NCT05121350: A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma |
|
|
| Recruiting | 3 | 256 | RoW | Anlotinib hydrochloride capsule, Epirubicin, Arotinib hydrochloride capsule placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Soft Tissue Sarcoma | 06/24 | 06/24 | | |
| Active, not recruiting | 3 | 90 | Europe, Canada, US, RoW | Pimicotinib(ABSK021), Placebo | Abbisko Therapeutics Co, Ltd | Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath | 05/26 | 06/28 | | |
OAIE, NCT05277480: Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma |
|
|
| Completed | 2 | 81 | RoW | Apatinib+IE, IE | Peking University People's Hospital, Jiangsu HengRui Medicine Co., Ltd. | Effect of Drug, Drug, Toxicity | 06/23 | 11/23 | | |
| Not yet recruiting | 2 | 118 | RoW | TQB3616 capsule, TQB3616 placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Dedifferentiated Liposarcoma | 04/24 | 12/24 | | |
NCT05046314: A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma |
|
|
| Recruiting | 2 | 30 | RoW | TK216+Vincristin | Shanghai Pharmaceuticals Holding Co., Ltd | Sarcoma, Ewing | 09/25 | 12/25 | | |
| Recruiting | 2 | 170 | RoW | HS-20093 | Hansoh BioMedical R&D Company | Osteosarcoma, Sarcoma | 12/25 | 12/27 | | |
TQB2858-I-05, NCT05154630: Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors |
|
|
| Terminated | 1/2 | 8 | RoW | TQB2858 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cancer, Advanced Soft-tissue Sarcoma | 03/23 | 06/23 | | |
NCT04448379: Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer |
|
|
| Recruiting | 1 | 48 | RoW | JMT101, Afatinib or Osimertinib | Shanghai JMT-Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Locally Advanced or Metastatic Non-Small Cell Lung Cancer | 12/21 | 06/22 | | |
| Recruiting | 1 | 96 | US, RoW | GQ1001 | GeneQuantum Healthcare (Suzhou) Co., Ltd., Conjugate Light (Australia) Pty Ltd | HER2-positive Breast Cancer, HER2-positive Biliary Tract Cancer, HER2-Positive Salivary Gland Carcinomas, HER2-Positive Advanced Solid Tumor | 03/24 | 05/24 | | |
NCT03687489: Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System |
|
|
| Active, not recruiting | N/A | 156 | RoW | Abdominal Aortic Aneurysm Stent Graft System | Lifetech Scientific (Shenzhen) Co., Ltd. | Abdominal Aortic Aneurysm | 11/20 | 03/25 | | |
NCT04731636: Guo's Visceral Arteries Reconstruction: First in Man Study |
|
|
| Completed | N/A | 15 | RoW | Thoracoabdominal aortic stent system | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm | 03/22 | 03/22 | | |
NCT03455855: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA |
|
|
| Completed | N/A | 72 | RoW | Jetstream System | Boston Scientific Corporation | Atherosclerosis | 02/23 | 01/24 | | |
NCT06478576: Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm |
|
|
| Recruiting | N/A | 73 | RoW | multibranched stent graft system | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal Aortic Aneurysm | 05/28 | 05/28 | | |
NCT05803564: Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm. |
|
|
| Recruiting | N/A | 46 | RoW | Thoracoabdominal aortic stent system | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal; Aortic, Aneurysm, Dissecting | 11/26 | 10/27 | | |
GENIUS, NCT04849325: IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease |
|
|
| Recruiting | N/A | 120 | RoW | Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titanâ„¢), Percutaneous Transluminal Angioplasty (PTA) Device | Biotyx Medical (Shenzhen) Co., Ltd. | Critical Limb Ischemia (CLI) | 04/24 | 10/24 | | |
NCT04982367: Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis |
|
|
| Recruiting | N/A | 166 | RoW | Sirolimus-eluting balloon catheter, Sirolimus coated balloon catheter, Paclitaxel-eluting balloon catheter, Paclitaxel coated balloon catheter | Acotec Scientific Co., Ltd | Peripheral Artery Disease | 07/24 | 07/24 | | |
NCT06605209: Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT) |
|
|
| Recruiting | N/A | 130 | RoW | Peripheral Balloon-Expandable Covered Stent System | Zhejiang Zylox Medical Device Co., Ltd. | Peripheral Artery Disease (PAD) | 07/26 | 12/26 | | |
NCT05246410: A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. |
|
|
| Recruiting | N/A | 196 | RoW | Spot stent system, Self-expanding peripheral stent system | Acotec Scientific Co., Ltd | Peripheral Vascular Disease (PVD), Peripheral Arterial Disease (PAD) | 11/24 | 12/24 | | |
NCT05054985: Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm. |
|
|
| Recruiting | N/A | 73 | RoW | Multi-Branched Thoracoabdominal Stent Graft System | Lifetech Scientific (Shenzhen) Co., Ltd. | Thoracoabdominal Aortic Aneurysms | 12/24 | 12/28 | | |
NCT05513664: Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer |
|
|
| Not yet recruiting | N/A | 80 | RoW | Osimertinib | Shanghai JMT-Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Locally Advanced or Metastatic Non-Small Cell Lung Cancer, EGFR Exon20 Insertion Mutations | 06/23 | 08/23 | | |
| Qu, Yan |
NCT05892653: A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors |
|
|
| Terminated | 1 | 15 | RoW | ABM-1310 | ABM Therapeutics Shanghai Company Limited | Primary Malignant Brain Tumor | 08/24 | 08/24 | | |
| Liu, Haixiao |
| No trials found |
| Cui, Wenxing |
| No trials found |
| Ge, Shunnan |
| No trials found |
| Wu, Xun |
| No trials found |
| Hu, Qing |
| No trials found |
